Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

Fast and accurate short read alignment with Burrows-Wheeler transform

Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607 · see citing works

Fast and accurate long-read alignment with Burrows-Wheeler transform.

Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063 · see citing works

Signatures of mutational processes in human cancer

Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · see citing works

Cancer Genome Landscapes

Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · see citing works

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · see citing works

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461 · see citing works

Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme

Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,475 · see citing works

Clonal evolution in cancer

Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162 · see citing works

Systematic identification of genomic markers of drug sensitivity in cancer cells

Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456 · see citing works

Massive genomic rearrangement acquired in a single catastrophic event during cancer development

Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414 · see citing works

Multiple Myeloma

Palumbo, A. P., & Anderson, K. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,338 · see citing works

Multiple myeloma

Raje, N. S., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,164 · see citing works

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058 · see citing works

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

Prahallad, A., Sun, C., Huang, S., Di Nicolantonio, F., Salazar, R., Zecchin, D., Beijersbergen, R. L., Bardelli, A., & Bernards, R. (2012) · Nature · doi:10.1038/nature10868 · Cited by 2,051 · see citing works

Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads

Ye, K., Schulz, M. H., Long, Q., Apweiler, R., & Ning, Z. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp394 · Cited by 1,978 · see citing works

Mutational Processes Molding the Genomes of 21 Breast Cancers

Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909 · see citing works

The landscape of cancer genes and mutational processes in breast cancer

Stephens, P. J., Tarpey, P. S., Davies, H. R., Loo, P. V., Greenman, C., Wedge, D. C., Nik‐Zainal, S., Martin, S., Varela, I., Bignell, G. R., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,686 · see citing works

The origin and evolution of mutations in acute myeloid leukemia

Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575 · see citing works

The Life History of 21 Breast Cancers

Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443 · see citing works

Initial genome sequencing and analysis of multiple myeloma

Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C. L., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,422 · see citing works

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379 · see citing works

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317 · see citing works

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Varela, I., Tarpey, P. S., Raine, K. M., Huang, D., Ong, C. K., Stephens, P., Davies, H. R., Jones, D., Lin, M., Teague, J. W., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,278 · see citing works

Deciphering Signatures of Mutational Processes Operative in Human Cancer

Alexandrov, L. B., Nik‐Zainal, S., Wedge, D. C., Campbell, P. J., & Stratton, M. R. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.008 · Cited by 1,277 · see citing works

Allele-specific copy number analysis of tumors

Loo, P. V., Nord, S., Lingjærde, O. C., Russnes, H. G., Rye, I. H., Sun, W., Weigman, V., Marynen, P., Zetterberg, A., Naume, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009843107 · Cited by 1,231 · see citing works

Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts

Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222 · see citing works

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

Roberts, S. A., Lawrence, M. S., Klimczak, L. J., Grimm, S. A., Fargo, D. C., Stojanov, P., Kieżun, A., Kryukov, G. V., Carter, S. L., Saksena, G., et al. (2013) · Nature Genetics · doi:10.1038/ng.2702 · Cited by 1,145 · see citing works

Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983 · see citing works

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Lohr, J. G., Stojanov, P., Lawrence, M. S., Auclair, D., Chapuy, B., Sougnez, C. L., Cruz‐Gordillo, P., Knoechel, B., Asmann, Y. W., Slager, S. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121343109 · Cited by 977 · see citing works

Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets

Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G., & Anderson, K. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2189 · Cited by 932 · see citing works

The genetic architecture of multiple myeloma

Morgan, G. J., Walker, B. A., & Davies, F. E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3257 · Cited by 913 · see citing works

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

Fonseca, R., Bergsagel, P. L., Drach, J. W., Shaughnessy, J. D., Gutierrez, N. C., Stewart, A. K., Morgan, G. J., Ness, B. V., Chesi, M., Minvielle, S., et al. (2009) · Leukemia · doi:10.1038/leu.2009.174 · Cited by 886 · see citing works

Genetic variegation of clonal architecture and propagating cells in leukaemia

Anderson, K., Lutz, C., van Delft, F. W., Bateman, C. M., Guo, Y., Colman, S., Kempski, H. M., Moorman, A. V., Titley, I., Swansbury, J. G., et al. (2010) · Nature · doi:10.1038/nature09650 · Cited by 803 · see citing works

Clonal competition with alternating dominance in multiple myeloma

Keats, J. J., Chesi, M., Egan, J. B., Garbitt, V. M., Palmer, S. E., Braggio, E., Wier, S. V., Blackburn, P. R., Baker, A. S., Dispenzieri, A. A., et al. (2012) · Blood · doi:10.1182/blood-2012-01-405985 · Cited by 636 · see citing works

Molecular pathogenesis and a consequent classification of multiple myeloma.

Bergsagel, P., & Kuehl, W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.021 · Cited by 554 · see citing works

Lymphotoxin ?, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface

Browning, J. L. (1993) · Cell · doi:10.1016/0092-8674(93)90574-a · Cited by 479 · see citing works

Chromosome translocations in multiple myeloma

Bergsagel, P. L., & Kuehl, W. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204641 · Cited by 478 · see citing works

Sorting out the cellular functions of sorting nexins

Worby, C. A., & Dixon, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm974 · Cited by 412 · see citing works

Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides

Egan, J. B., Shi, C.-X., Tembe, W., Christoforides, A., Kurdoglu, A. A., Sinari, S. A., Middha, S., Asmann, Y. W., Schmidt, J. E., Braggio, E., et al. (2012) · Blood · doi:10.1182/blood-2012-01-405977 · Cited by 404 · see citing works

Bayesian Markov chain Monte Carlo sequence analysis reveals varying neutral substitution patterns in mammalian evolution

Hwang, D. G., & Green, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404142101 · Cited by 390 · see citing works

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

Bernardo, M. C. D., Crowther-Swanepoel, D., Broderick, P., Webb, E. L., Sellick, G. S., Wild, R., Sullivan, K., Vijayakrishnan, J., Wang, Y., Pittman, A. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.219 · Cited by 356 · see citing works

The Implications of Clonal Genome Evolution for Cancer Medicine

Aparicio, S. A. J. R., & Caldas, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1204892 · Cited by 350 · see citing works

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma

Kridel, R., Meissner, B., Rogić, S., Boyle, M., Telenius, A., Woolcock, B. W., Gunawardana, J., Jenkins, C. R., Cochrane, C., Ben‐Neriah, S., et al. (2011) · Blood · doi:10.1182/blood-2011-11-391474 · Cited by 335 · see citing works

Classical and/or alternative NF-κB pathway activation in multiple myeloma

Demchenko, Y. N., Glebov, O. K., Zingone, A., Keats, J. J., Bergsagel, P. L., & Kuehl, W. M. (2010) · Blood · doi:10.1182/blood-2009-09-243535 · Cited by 289 · see citing works

Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms

Walker, B. A., Wardell, C. P., Melchor, L., Brioli, A., Johnson, D. C., Kaiser, M., Mirabella, F., López‐Corral, L., Humphray, S., Murray, L., et al. (2013) · Leukemia · doi:10.1038/leu.2013.199 · Cited by 283 · see citing works

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma

Walker, B. A., Wardell, C. P., Melchor, L., Wilson, S. H., Potter, N. E., Johnson, D. C., Fenwick, K., Kozarewa, I., Gonzalez, D., Lord, C. J., et al. (2012) · Blood · doi:10.1182/blood-2012-03-412981 · Cited by 246 · see citing works

Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment

Callahan, M. K., Rampal, R. K., Harding, J. J., Klimek, V. M., Chung, Y. R., Merghoub, T., Wolchok, J. D., Solit, D. B., Rosen, N. X., Abdel-Wahab, O. I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208958 · Cited by 237 · see citing works

Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma

Tarpey, P. S., Behjati, S., Cooke, S. L., Loo, P. V., Wedge, D. C., Pillay, N., Marshall, J., O’Meara, S., Davies, H. R., Nik‐Zainal, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2668 · Cited by 221 · see citing works

Function and cancer genomics of FAT family genes

Katoh, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1669 · Cited by 213 · see citing works

Functions and regulation of the APOBEC family of proteins

Smith, H. C., Bennett, R. P., Kizilyer, A., McDougall, W. M., & Prohaska, K. M. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.10.004 · Cited by 203 · see citing works

Expression of the AID protein in normal and neoplastic B cells

Pasqualucci, L., Guglielmino, R., Houldsworth, J., Mohr, J., Aoufouchi, S., Polakiewicz, R. D., CHAGANTI, R. S. K., & Dalla‐Favera, R. (2004) · Blood · doi:10.1182/blood-2004-04-1558 · Cited by 193 · see citing works

Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival

Boyd, K. D., Ross, F. M., Walker, B. A., Wardell, C. P., Tapper, W., Chiecchio, L., Dagrada, G. P., Konn, Z. J., Gregory, W. M., Jackson, G. H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1791 · Cited by 174 · see citing works

Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer

Greenman, C., Wooster, R., Futreal, P. A., Stratton, M. R., & Easton, D. F. (2006) · Genetics · doi:10.1534/genetics.105.044677 · Cited by 163 · see citing works

Peg3/Pw1 is an imprinted gene involved in the TNF-NFκB signal transduction pathway

Relaix, F., Wei, X.-J., Wu, X., & Sassoon, D. A. (1998) · Nature Genetics · doi:10.1038/ng0398-287 · Cited by 152 · see citing works

JTV1 co‐activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress

Liu, J., Chung, H., Vogt, M., Jin, Y., Malide, D., He, L., Dundr, M., & Levens, D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.11 · Cited by 141 · see citing works

Minor clone provides a reservoir for relapse in multiple myeloma

Magrangeas, F., Avet‐Loiseau, H., Gouraud, W., Lodé, L., Decaux, O., Godmer, P., Garderet, L., Voillat, L., Facon, T. T. F., Stoppa, A., et al. (2012) · Leukemia · doi:10.1038/leu.2012.226 · Cited by 121 · see citing works

RAF inhibition and induction of cutaneous squamous cell carcinoma

Robert, C., Arnault, J., & Mateus, C. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283436e8c · Cited by 119 · see citing works

Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma

Chen, L., Wang, S., Zhou, Y., Wu, X., Entin, I., Epstein, J., Yaccoby, S., Xiong, W., Barlogie, B., Shaughnessy, J. D., et al. (2009) · Blood · doi:10.1182/blood-2009-03-210526 · Cited by 86 · see citing works

Implication of the Lymphocyte-Specific Nuclear Body Protein Sp140 in an Innate Response to Human Immunodeficiency Virus Type 1

Madani, N., Millette, R. L., Platt, E. J., Marin, M., Kozak, S. L., Bloch, D. B., & Kabat, D. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.11133-11138.2002 · Cited by 60 · see citing works

Concerted and Stepwise Dehydration Mechanisms Observed in Wild-Type and Mutated Escherichia coli dTDP-Glucose 4,6-Dehydratase

Hegeman, A. D., Gross, J. W., & Frey, P. A. (2002) · Biochemistry · doi:10.1021/bi011748c · Cited by 34 · see citing works

Purification of a novel ras GTPase-activating protein from rat brain.

Maekawa, M., Nakamura, S., & Hattori, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41618-3 · Cited by 28 · see citing works

Two evolutionarily conserved sequence elements for Peg3/Usp29 transcription

Kim, J., Yu, S., Choo, J. H., & Kim, J. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-108 · Cited by 16 · see citing works

Clonal heterogeneity and tumor evolution: past, present, and the future

McGranahan, N., & Swanton, C. (2017) · Cell · doi:10.1016/j.cell.2017.01.018 · Cited by 2,840 · see citing works

Universal Patterns of Selection in Cancer and Somatic Tissues

Martincorena, I., Raine, K. M., Gerstung, M., Dawson, K. J., Haase, K., Van Loo, P., Davies, H., Stratton, M. R., & Campbell, P. J. (2017) · Cell · doi:10.1016/j.cell.2017.09.042 · Cited by 1,523 · see citing works

The evolutionary history of lethal metastatic prostate cancer

ICGC Prostate UK Group, Gundem, G., Loo, P. V., Kremeyer, B., Alexandrov, L. B., Tubío, J. M. C., Papaemmanuil, E., Brewer, D. S., Kallio, H. M. L., Högnäs, G., et al. (2015) · Nature · doi:10.1038/nature14347 · Cited by 1,358 · see citing works

Multiple myeloma

Kumar, S. K., Rajkumar, S. V., Kyle, R. A., van Duin, M., Sonneveld, P., Mateos, M., Gay, F., & Anderson, K. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.46 · Cited by 1,235 · see citing works

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

de Bruin, E. C., McGranahan, N., Mitter, R., Salm, M., Wedge, D. C., Yates, L., Jamal-Hanjani, M., Shafi, S., Murugaesu, N., Rowan, A. J., et al. (2014) · Science · doi:10.1126/science.1253462 · Cited by 1,117 · see citing works

Mutational signatures associated with tobacco smoking in human cancer

Alexandrov, L. B., Ju, Y. S., Haase, K., Van Loo, P., Martincorena, I., Nik-Zainal, S., Totoki, Y., Fujimoto, A., Nakagawa, H., Shibata, T., et al. (2016) · Science · doi:10.1126/science.aag0299 · Cited by 1,100 · see citing works

Biological and therapeutic impact of intratumor heterogeneity in cancer evolution

McGranahan, N., & Swanton, C. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.001 · Cited by 1,077 · see citing works

Clock-like mutational processes in human somatic cells

Alexandrov, L. B., Jones, P. H., Wedge, D. C., Sale, J. E., Campbell, P. J., Nik‐Zainal, S., & Stratton, M. R. (2015) · Nature Genetics · doi:10.1038/ng.3441 · Cited by 1,038 · see citing works

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

Zhang, J., Fujimoto, J., Zhang, J., Wedge, D. C., Song, X., Zhang, J., Seth, S., Chow, C.-W., Cao, Y., Gumbs, C., et al. (2014) · Science · doi:10.1126/science.1256930 · Cited by 965 · see citing works

Subclonal diversification of primary breast cancer revealed by multiregion sequencing

Yates, L. R., Gerstung, M., Knappskog, S., Desmedt, C., Gundem, G., Loo, P. V., Aas, T., Alexandrov, L. B., Larsimont, D., Davies, H., et al. (2015) · Nature Medicine · doi:10.1038/nm.3886 · Cited by 812 · see citing works

T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Brudno, J. N., Marić, I., Hartman, S. D., Rose, J. J., Wang, M., Lam, N., Stetler‐Stevenson, M., Salem, D., Yuan, C. M., Pavletic, S. Z., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.77.8084 · Cited by 778 · see citing works

Clonal status of actionable driver events and the timing of mutational processes in cancer evolution

McGranahan, N., Favero, F., de Bruin, E. C., Birkbak, N. J., Szallasi, Z., & Swanton, C. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1408 · Cited by 685 · see citing works

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Walker, B. A., Boyle, E. M., Wardell, C. P., Murison, A., Begum, D. B., Dahir, N. M., Proszek, P. Z., Johnson, D. C., Kaiser, M. F., Melchor, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1503 · Cited by 567 · see citing works

Genomic complexity of multiple myeloma and its clinical implications

Manier, S., Salem, K. Z., Park, J., Landau, D. A., Getz, G. A., & Ghobrial, I. M. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.122 · Cited by 552 · see citing works

Translational Implications of Tumor Heterogeneity

Jamal‐Hanjani, M., Quezada, S. A., Larkin, J., & Swanton, C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1429 · Cited by 549 · see citing works

Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

Dentro, S. C., Leshchiner, I., Haase, K., Tarabichi, M., Wintersinger, J., Deshwar, A. G., Yu, K., Rubanova, Y., Macintyre, G., Demeulemeester, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.009 · Cited by 533 · see citing works

Detecting ultralow-frequency mutations by Duplex Sequencing

Kennedy, S. R., Schmitt, M. W., Fox, E. J., Kohrn, B. F., Salk, J. J., Ahn, E. H., Prindle, M. J., Kuong, K. J., Shen, J.-C., Risques, R.-A., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.170 · Cited by 503 · see citing works

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

Mitchell, T. J., Turajlic, S., Rowan, A., Nicol, D. L., Farmery, J. H. R., O’Brien, T., Martincorena, I., Tarpey, P. S., Angelopoulos, N., Yates, L. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.020 · Cited by 502 · see citing works

APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity

Swanton, C., McGranahan, N., Starrett, G. J., & Harris, R. S. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0344 · Cited by 480 · see citing works

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

Walker, B. A., Mavrommatis, K., Wardell, C. P., Ashby, T. C., Bauer, M., Davies, F. E., Rosenthal, A., Wang, H., Qu, P., Hoering, A., et al. (2018) · Blood · doi:10.1182/blood-2018-03-840132 · Cited by 475 · see citing works

Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)

Katoh, M. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4129 · Cited by 467 · see citing works

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

Walker, B. A., Mavrommatis, K., Wardell, C. P., Ashby, C., Bauer, M., Davies, F. E., Rosenthal, A., Wang, H., Qu, P., Hoering, A., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0196-8 · Cited by 445 · see citing works

SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution

Miller, C. A., White, B. S., Dees, N. D., Griffith, M., Welch, J. S., Griffith, O. L., Vij, R., Tomasson, M. H., Graubert, T. A., Walter, M. J., et al. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003665 · Cited by 444 · see citing works

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Rasche, L., Chavan, S. S., Stephens, O. W., Patel, P. H., Tytarenko, R., Ashby, C., Bauer, M., Stein, C., Deshpande, S., Wardell, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00296-y · Cited by 417 · see citing works

Tumour heterogeneity and the evolution of polyclonal drug resistance

Burrell, R. A., & Swanton, C. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.06.005 · Cited by 417 · see citing works

Hypermutation in human cancer genomes: footprints and mechanisms

Roberts, S. A., & Gordenin, D. A. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3816 · Cited by 397 · see citing works

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

Nijhof, I. S., Casneuf, T., van Velzen, J. F., van Kessel, B., Axel, A. E., Syed, K. W., Groen, R. W. J., van Duin, M., Sonneveld, P., Minnema, M. C., et al. (2016) · Blood · doi:10.1182/blood-2016-03-703439 · Cited by 393 · see citing works

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche

Lawson, M. A., McDonald, M. M., Kovačić, N., Khoo, W. H., Terry, R. L., Down, J. M., Kaplan, W. H., Paton‐Hough, J., Fellows, C., Pettitt, J. A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9983 · Cited by 385 · see citing works

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer

Hong, M. K. H., Macintyre, G., Wedge, D. C., Loo, P. V., Patel, K., Lunke, S., Alexandrov, L. B., Sloggett, C., Cmero, M., Marass, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms7605 · Cited by 367 · see citing works

Integrated genomic characterization of IDH1-mutant glioma malignant progression

Bai, H., Harmancı, A. S., Erson-Omay, Z., Li, J., Coşkun, S., Simon, M., Krischek, B., Özduman, K., Omay, S. B., Sorensen, E. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3457 · Cited by 324 · see citing works

The evolution of tumour phylogenetics: principles and practice

Schwartz, R. S., & Schäffer, A. A. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.170 · Cited by 317 · see citing works

Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics

Li, X., Francies, H. E., Secrier, M., Perner, J., Miremadi, A., Galeano-Dalmau, N., Barendt, W. J., Letchford, L., Leyden, G. M., Goffin, E. K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05190-9 · Cited by 316 · see citing works

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

Korde, N., Roschewski, M. J., Zingone, A., Kwok, M., Manasanch, E. E., Bhutani, M., Tageja, N., Kazandjian, D. G., Mailankody, S., Wu, P., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2010 · Cited by 306 · see citing works

Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival

Morris, L. G. T., Riaz, N., Desrichard, A., Şenbabaoğlu, Y., Hakimi, A. A., Makarov, V., Reis-Filho, J. S., & Chan, T. A.-T. (2016) · Oncotarget · doi:10.18632/oncotarget.7067 · Cited by 297 · see citing works

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution

Efremova, M., Rieder, D., Klepsch, V., Charoentong, P., Finotello, F., Hackl, H., Hermann‐Kleiter, N., Löwer, M., Baier, G., Krogsdam, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02424-0 · Cited by 295 · see citing works

Pathogenesis beyond the cancer clone(s) in multiple myeloma

Bianchi, G., & Munshi, N. C. (2015) · Blood · doi:10.1182/blood-2014-11-568881 · Cited by 285 · see citing works

Genomic landscape and chronological reconstruction of driver events in multiple myeloma

Maura, F., Bolli, N., Angelopoulos, N., Dawson, K. J., Leongamornlert, D., Martincorena, I., Mitchell, T. J., Fullam, A., Gonzalez, S., Szalat, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11680-1 · Cited by 278 · see citing works

Mutational signatures of ionizing radiation in second malignancies

Behjati, S., Gundem, G., Wedge, D. C., Roberts, N. D., Tarpey, P. S., Cooke, S. L., Van Loo, P., Alexandrov, L. B., Ramakrishna, M., Davies, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms12605 · Cited by 274 · see citing works

CAR T cell therapies for patients with multiple myeloma

Mikkilineni, L., & Kochenderfer, J. N. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0427-6 · Cited by 270 · see citing works

B Cell Super-Enhancers and Regulatory Clusters Recruit AID Tumorigenic Activity

Qian, J., Wang, Q., Dose, M., Pruett, N. D., Kieffer-Kwon, K.-R., Resch, W., Liang, G., Tang, Z., Mathé, E. A., Benner, C. W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.013 · Cited by 266 · see citing works

Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma

Ledergor, G., Weiner, A., Zada, M., Wang, S.-Y., Cohen, Y. C., Gatt, M. E., Snir, N., Magen, H., Koren-Michowitz, M., Herzog-Tzarfati, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0269-2 · Cited by 263 · see citing works

The kinome 'at large' in cancer

Fleuren, E. D. G., Zhang, L., Wu, J., & Daly, R. J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2015.18 · Cited by 261 · see citing works

Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes

Kortüm, K. M., Mai, E. K., Hanafiah, N. H., Shi, C.-X., Zhu, Y.-X., Bruins, L., Barrio, S., Jedlowski, P., Merz, M., Xu, J., et al. (2016) · Blood · doi:10.1182/blood-2016-02-698092 · Cited by 255 · see citing works

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer

Tisato, V., Voltan, R., Gonelli, A., Secchiero, P., & Zauli, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0500-5 · Cited by 255 · see citing works

Clonal expansion in non-cancer tissues

Kakiuchi, N., & Ogawa, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00335-3 · Cited by 252 · see citing works

Diagnosis and classification of hematologic malignancies on the basis of genetics

Taylor, J., Xiao, W., & Abdel-Wahab, O. I. (2017) · Blood · doi:10.1182/blood-2017-02-734541 · Cited by 251 · see citing works

Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer

Li, R., Ferdinand, J. R., Loudon, K. W., Bowyer, G., Laidlaw, S., Muyas, F., Mamanova, L., Neves, J. B., Bolt, L., Fasouli, E. S., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.11.001 · Cited by 242 · see citing works

Evolutionary biology of high-risk multiple myeloma

Pawlyn, C., & Morgan, G. J. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.63 · Cited by 237 · see citing works

Genomic and evolutionary classification of lung cancer in never smokers

Zhang, T., Joubert, P., Ansari‐Pour, N., Wei, Z., Hoang, P. H., Lokanga, R. A., Moye, A. L., Rosenbaum, J., González-Pérez, A., Martínez-Jiménez, F., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00920-0 · Cited by 235 · see citing works

Multiple Myeloma: Available Therapies and Causes of Drug Resistance

Pinto, V., Bergantim, R., Caires, H. R., Seca, H., Guimarães, J. E., & Vasconcelos, M. H. (2020) · Cancers · doi:10.3390/cancers12020407 · Cited by 233 · see citing works

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

CAMCAP Study Group, Wedge, D. C., Gundem, G., Mitchell, T., Woodcock, D. J., Martincorena, I., Ghori, M., Zamora, J., Butler, A. P., Whitaker, H. C., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0086-z · Cited by 223 · see citing works

A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma

Mei, H., Li, C., Jiang, H., Zhao, X., Huang, Z., Jin, D., Guo, T., Kou, H., Liu, L., Tang, L., et al. (2021) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-021-01170-7 · Cited by 222 · see citing works

Genomic patterns of progression in smoldering multiple myeloma

Bolli, N., Maura, F., Minvielle, S., Gloznik, D., Szalat, R., Fullam, A., Martincorena, I., Dawson, K. J., Samur, M. K., Zamora, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05058-y · Cited by 222 · see citing works

Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine

Hiley, C. T., de Bruin, E. C., McGranahan, N., & Swanton, C. (2014) · Genome biology · doi:10.1186/s13059-014-0453-8 · Cited by 221 · see citing works

Chimeric antigen receptor T-cell therapies for multiple myeloma

Mikkilineni, L., & Kochenderfer, J. N. (2017) · Blood · doi:10.1182/blood-2017-06-793869 · Cited by 213 · see citing works

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

Weinhold, N., Ashby, C., Rasche, L., Chavan, S. S., Stein, C., Stephens, O., Tytarenko, R. G., Bauer, M., Meißner, T., Deshpande, S., et al. (2016) · Blood · doi:10.1182/blood-2016-06-723007 · Cited by 212 · see citing works

The origins and genetic interactions of KRAS mutations are allele- and tissue-specific

Cook, J. H., Melloni, G. E. M., Gulhan, D. C., Park, P. J., & Haigis, K. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22125-z · Cited by 208 · see citing works

Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas

Ding, X., He, M., Chan, A. W. H., Song, Q. X., Sze, S. C., Chen, H., Man, K., Man, K., Chan, S. L., Lai, P. B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.09.005 · Cited by 208 · see citing works

Spatial genomics maps the structure, nature and evolution of cancer clones

Lomakin, A., Svedlund, J., Strell, C., Gatarić, M., Shmatko, A., Rukhovich, G. D., Park, J. S., Ju, Y. S., Dentro, S. C., Kleshchevnikov, V., et al. (2022) · Nature · doi:10.1038/s41586-022-05425-2 · Cited by 206 · see citing works

Next-generation sequencing: advances and applications in cancer diagnosis

Serratì, S., Summa, S. D., Pilato, B., Petriella, D., Lacalamita, R., Tommasi, S., & Pinto, R. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s99807 · Cited by 203 · see citing works

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups

Bolli, N., Biancon, G., Moarii, M., Gimondi, S., Li, Y., Philippis, C. D., Maura, F., Sathiaseelan, V., Tai, Y., Mudie, L. J., et al. (2017) · Leukemia · doi:10.1038/s41375-018-0037-9 · Cited by 201 · see citing works

Toward personalized treatment in multiple myeloma based on molecular characteristics

Pawlyn, C., & Davies, F. E. (2018) · Blood · doi:10.1182/blood-2018-09-825331 · Cited by 201 · see citing works

Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options

van Andel, H., Kocemba, K. A., Spaargaren, M., & Pals, S. T. (2019) · Leukemia · doi:10.1038/s41375-019-0404-1 · Cited by 188 · see citing works

Clusters of Multiple Mutations: Incidence and Molecular Mechanisms

Chan, K., & Gordenin, D. A. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-054714 · Cited by 187 · see citing works

A practical guide for mutational signature analysis in hematological malignancies

Maura, F., Degasperi, A., Nadeu, F., Leongamornlert, D., Davies, H., Moore, L., Royo, R., Ziccheddu, B., Puente, X. S., Avet-Loiseau, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11037-8 · Cited by 184 · see citing works

Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells

Vinci, M., Burford, A., Molinari, V., Kessler, K., Popov, S., Clarke, M., Taylor, K. R., Pemberton, H. N., Lord, C. J., Gutteridge, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0086-7 · Cited by 181 · see citing works

A mutational signature in gastric cancer suggests therapeutic strategies

Alexandrov, L. B., Nik‐Zainal, S., Siu, H. C., Leung, S. Y., & Stratton, M. R. (2015) · Nature Communications · doi:10.1038/ncomms9683 · Cited by 178 · see citing works

MGUS to myeloma: a mysterious gammopathy of underexplored significance

Dhodapkar, M. V. (2016) · Blood · doi:10.1182/blood-2016-09-692954 · Cited by 175 · see citing works

Progress and Paradigms in Multiple Myeloma

Anderson, K. C. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0625 · Cited by 171 · see citing works

Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant

Mouhieddine, T. H., Sperling, A. S., Redd, R. A., Park, J., Leventhal, M. J., Gibson, C. J., Manier, S., Nassar, A. H., Capelletti, M., Huynh, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16805-5 · Cited by 171 · see citing works

Timing the Initiation of Multiple Myeloma

Rustad, E. H., Yellapantula, V., Leongamornlert, D., Bolli, N., Ledergor, G., Nadeu, F., Angelopoulos, N., Dawson, K. J., Mitchell, T. J., Osborne, R. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15740-9 · Cited by 165 · see citing works

High-Definition Reconstruction of Clonal Composition in Cancer

Fischer, A., Vázquez-Garćıa, I., Illingworth, C. J. R., & Mustonen, V. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.055 · Cited by 162 · see citing works

New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple Myeloma

Landgren, O., & Rajkumar, S. V. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0866 · Cited by 159 · see citing works

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when

Caers, J., Garderet, L., Kortüm, K. M., O'Dwyer, M. E., van de Donk, N. W. C. J., Binder, M., Dold, S. M., Gay, F., Corre, J., Beguin, Y. P., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.189159 · Cited by 153 · see citing works

Genetic interrogation of circulating multiple myeloma cells at single-cell resolution

Lohr, J. G., Kim, S., Gould, J., Knoechel, B., Drier, Y., Cotton, M. J., Gray, D. H. D., Birrer, N., Wong, B., Ha, G., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7037 · Cited by 150 · see citing works

Inferring the Mutational History of a Tumor Using Multi-state Perfect Phylogeny Mixtures

El-Kebir, M., Satas, G., Oesper, L., & Raphael, B. J. (2016) · Cell Systems · doi:10.1016/j.cels.2016.07.004 · Cited by 146 · see citing works

Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics

Tirier, S. M., Mallm, J., Steiger, S., Poos, A. M., Awwad, M. H. S., Giesen, N., Casiraghi, N. A., Sušak, H., Bauer, K., Baumann, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26951-z · Cited by 146 · see citing works

High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma

Miller, A., Asmann, Y., Cattaneo, L., Braggio, E., Keats, J., Auclair, D., Lonial, S., The MMRF CoMMpass Network, Russell, S. J., & Stewart, A. K. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.94 · Cited by 145 · see citing works

Genetics of multiple myeloma: another heterogeneity level?

Corre, J., Munshi, N. C., & Avet‐Loiseau, H. (2015) · Blood · doi:10.1182/blood-2014-10-567370 · Cited by 145 · see citing works

Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update

Nijhof, I. S., van de Donk, N. W. C. J., Zweegman, S., & Lokhorst, H. M. (2017) · Drugs · doi:10.1007/s40265-017-0841-y · Cited by 144 · see citing works

Therapy for Relapsed Multiple Myeloma

Dingli, D., Ailawadhi, S., Bergsagel, P. L., Buadi, F. K., Dispenzieri, A. A., Fonseca, R., Gertz, M. A., Gonsalves, W. I., Hayman, S. R., Kapoor, P., et al. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.01.003 · Cited by 140 · see citing works

Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates

Kis, O., Kaedbey, R., Chow, S., Danesh, A., Dowar, M., Li, T., Li, Z., Liu, J., Mansour, M., Masih‐Khan, E., et al. (2017) · Nature Communications · doi:10.1038/ncomms15086 · Cited by 137 · see citing works

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability

Dutta, A. K., Fink, J. L., Grady, J. P., Morgan, G. J., Mullighan, C. G., To, L. B., Hewett, D. R., & Zannettino, A. C. W. (2018) · Leukemia · doi:10.1038/s41375-018-0206-x · Cited by 137 · see citing works

Multiple myeloma: the (r)evolution of current therapy and a glance into future

Gullà, A., & Anderson, K. C. (2020) · Haematologica · doi:10.3324/haematol.2020.247015 · Cited by 137 · see citing works

Principles of Reconstructing the Subclonal Architecture of CancersPreprint

Dentro, S. C., Wedge, D. C., & Loo, P. V. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026625 · Cited by 134 · see citing works

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

Bianchi, G., & Anderson, K. C. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21252 · Cited by 133 · see citing works

Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies

Lee, J. J.-K., Choi, Y., Kwon, M., & Park, P. J. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044446 · Cited by 132 · see citing works

Co-evolution of tumor and immune cells during progression of multiple myeloma

Liu, R., Gao, Q., Foltz, S. M., Fowles, J. S., Yao, L., Wang, J. T., Cao, S., Sun, H., Wendl, M. C., Sethuraman, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22804-x · Cited by 132 · see citing works

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia

Gambacorti-Passerini, C. B., Donadoni, C., Parmiani, A., Pirola, A., Redaelli, S., Signore, G., Piazza, V., Malcovati, L., Fontana, D., Spinelli, R., et al. (2014) · Blood · doi:10.1182/blood-2014-06-579466 · Cited by 129 · see citing works

Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma

Lazzari, E., Mondala, P. K., Santos, N. P. D., Miller, A. C., Pineda, G., Jiang, Q., Leu, H. S., Ali, S. A., Ganesan, A.-P., Wu, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01890-w · Cited by 129 · see citing works

Single-cell profiling of tumour evolution in multiple myeloma — opportunities for precision medicine

Dutta, A. K., Alberge, J.-B., Sklavenitis‐Pistofidis, R., Lightbody, E. D., Getz, G. A., & Ghobrial, I. M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00593-y · Cited by 128 · see citing works

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities

Wang, B., Pei, J., Xu, S., Liu, J., & Yu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1246682 · Cited by 126 · see citing works

Spectrum and functional validation of PSMB5 mutations in multiple myeloma

Barrio, S., Stühmer, T., Vià, M. D., Barrio-Garcia, C., Lehners, N., Bešše, A., Cuenca, I., Garitano-Trojaola, A., Fink, S., Leich, E., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0216-8 · Cited by 124 · see citing works

The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma

Vrábel, D., Pour, L., & Ševčíková, S. (2019) · Blood Reviews · doi:10.1016/j.blre.2018.11.003 · Cited by 123 · see citing works

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

Chrétien, M., Corre, J., Lauwers‐Cancès, V., Magrangeas, F., Cleynen, A., Yon, E., Hulin, C., Leleu, X. P., Orsini‐Piocelle, F., Blade, J., et al. (2015) · Blood · doi:10.1182/blood-2015-06-650242 · Cited by 121 · see citing works

Multiple myeloma clonal evolution in homogeneously treated patients

Corre, J., Cleynen, A., Robiou-du-Pont, S., Buisson, L., Bolli, N., Attal, M., Munshi, N. C., & Avet‐Loiseau, H. (2018) · Leukemia · doi:10.1038/s41375-018-0153-6 · Cited by 121 · see citing works

The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma

Mishima, Y., Paiva, B., Shi, J., Park, J., Manier, S., Takagi, S., Massoud, M. R., Perilla-Glen, A., Aljawai, Y. M., Huynh, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.025 · Cited by 119 · see citing works

The impact of intra-clonal heterogeneity on the treatment of multiple myeloma

Brioli, A., Melchor, L., Cavo, M., & Morgan, G. J. (2014) · British Journal of Haematology · doi:10.1111/bjh.12805 · Cited by 114 · see citing works

Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma

Cottini, F., Hideshima, T., Suzuki, R., Tai, Y., Bianchini, G., Richardson, P. G. G., Anderson, K. C., & Tonon, G. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0943 · Cited by 114 · see citing works

The KDM3A–KLF2–IRF4 axis maintains myeloma cell survival

Ohguchi, H., Hideshima, T., Bhasin, M., Görgün, G., Santo, L., Cea, M., Samur, M., Mimura, N., Suzuki, R., Tai, Y.-T., et al. (2016) · Nature Communications · doi:10.1038/ncomms10258 · Cited by 114 · see citing works

P-047: Clonal evolution in multiple myeloma evaluated by Whole Exome Sequencing

Gupta, R., Kaur, G., Farswan, A., Jena, L., Gupta, A., Rani, L., Kumar, L., & Sharma, A. (2021) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/s2152-2650(21)02181-9

Whole Exome Sequencing Of Multiple Myeloma Reveals An Heterogeneous Clonal Architecture and Genomic Evolution

Bolli, N., Avet‐Loiseau, H., Wedge, D. C., Loo, P. V., Alexandrov, L. B., Martin, S., Dawson, K. J., Iorio, F., Nik‐Zainal, S., Bignell, G. R., et al. (2013) · Blood · doi:10.1182/blood.v122.21.399.399 · Cited by 1 · see citing works

Genomic Evolution and Clinical Correlates

Campbell, P. J. (2013) · Blood · doi:10.1182/blood.v122.21.sci-15.sci-15

Multiple Myeloma Sequencing Reveals Subclonality and Timing of Genetic Alterations

Lohr, J. G., Stojanov, P., Lawrence, M. S., Auclair, D., Carter, S. L., Sougnez, C. L., Gould, J., Cruz‐Gordillo, P., Chapman, M. A., Getz, G. A., et al. (2011) · Blood · doi:10.1182/blood.v118.21.2897.2897

Genomic complexity of multiple myeloma and its clinical implications

Manier, S., Salem, K. Z., Park, J., Landau, D. A., Getz, G. A., & Ghobrial, I. M. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.122 · Cited by 552 · see citing works